Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer

NCT00193401 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Topotecan

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]